INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Clinical trials for INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled therapy aims to halt progressive lung scarring
Disease control Recruiting nowThis study tests an inhaled form of pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis (PPF), a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their usual care. T…
Matched conditions: INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New screening method aims to catch lung issues early in arthritis patients
Knowledge-focused Recruiting nowThis study is looking for 800 adults with rheumatoid arthritis in Austria to help develop a standard screening method for lung problems. Researchers will use CT scans and other tests to see which patients are at high risk. The goal is to catch lung issues early, but this study do…
Matched conditions: INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
Sponsor: Medical University Innsbruck • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC